Survival estimates are reported in the Fig. There were 192 patients (47%) who were deemed ineligible for or declined treatment. Reintervention was common and occurred at a significantly higher rate in the hybrid group compared with other groups (rates for hybrid, endovascular, partial, and open were 46%, 28%, 26%, and 18%, respectively).
Objective: The use of duplex ultrasound for surveillance after fenestrated endovascular aneurysm repair (FEVAR) is not well studied. Our objective was to further characterize normal and abnormal duplex ultrasound findings in renal branch grafts after FEVAR.
Methods: We retrospectively reviewed a single-center experience involving consecutive patients treated with the Zenith fenestrated endovascular graft (ZFEN) device (Cook Medical, Bloomington, Ind) . Postoperative imaging with computed tomography (CT) angiography was obtained at usual intervals. As experience progressed, duplex ultrasound was obtained in a nonstandardized protocol, particularly in patients with reduced renal function. Loss of renal patency was defined as occlusion or stenosis >50%.
Results: A total of 116 patients were treated with FEVAR, of whom 60 (51.7%) had concurrent CT and renal duplex ultrasound images available for review. Six patients (10%) had limited ultrasound studies because of bowel gas and were excluded. This left a total of 94 renal stents placed in 54 patients with a mean follow-up of 23 months. Twelve cases of renal patency loss in 10 patients (9 stenoses, 3 occlusions) were found on CT, 11 (91.6%) of which had concurrent abnormalities found on ultrasound. Stents with compression at the fenestration junction exhibited elevated mean peak systolic velocities (PSVs) compared with nonstenosed stents (349.2 vs 115.3 cm/s; P ¼ .003). Stenosis in the most proximal portion of the stent (ie, within the main body) showed no difference in proximal PSVs (86.0 vs 131.9 cm/s; P ¼ .257) but showed significantly dampened PSVs in the mid (17.5 vs 109.9 cm/s; P ¼ .027) and distal (19.0 vs 78.3 cm/s; P ¼ .028) segments compared with nonstenosed stents. All occluded stents demonstrated no flow detection. Proximal PSV served as a strong classifier for junctional stenosis (area under the curve, 0.98; Fig) . A combined criterion of proximal PSV >215 cm/s or distal PSV <25 cm/s resulted in a sensitivity of 91.6% and specificity of 85.3% for detecting patency loss. All stents underwent successful reintervention. Seven of 10 (70%) patients had detectable >25% increase in serum creatinine concentration associated with renal patency loss.
Conclusions: Duplex ultrasound is a clinically useful modality for surveillance of renal branch grafts after FEVAR. Patterns of segmental velocity elevation (proximal PSV >215 cm/s) and dampening in the distal renal segment indicate potential hemodynamic compromise, and those patients should be considered for secondary intervention. Objective: Treatment of type B aortic dissections with thoracic endovascular aortic repair (TEVAR) has been adopted in many centers with the goal of covering the proximal entry tear. Coverage of the left subclavian artery is commonly required to achieve a dissection-free proximal seal zone. A novel thoracic single side-branched (TSSB) endograft offers a potential off-the-shelf option to achieve total endovascular incorporation of the left subclavian artery during zone 2 TEVAR. The aim of this study was to determine what percentage of patients with type B aortic dissection who require zone 2 TEVAR meet the anatomic requirements for this device.
Methods: All consecutive patients undergoing TEVAR for type B aortic dissections at a single institution from 2006 to 2016 were evaluated. Three-dimensional centerline reconstruction of preoperative computed tomography angiography was performed to identify the diameter of the aorta, distances between branch vessels, diameter of the target branch vessel, and location of the primary entry tear. Only patients who required zone 2 TEVAR were included in the analysis. The primary outcome was percentage of patients who met all anatomic requirements for the TSSB endograft. The specific requirements leading to nonsuitability were also calculated. Results: Eighty-seven patients who underwent TEVAR for type B aortic dissection were reviewed; 57 of 87 would have required zone 2 TEVAR. Indications for TEVAR were malperfusion (12), aneurysm (15), persistent pain (22), rupture (3), uncontrolled hypertension (5), and other (3). Mean followup was 19 months (range, 1-72 months). Only 17 patients (30%) met all the requirements for anatomic suitability (Fig) . The reasons for failing anatomic suitability were covered stent graft length proximal to the branch portal (61%), aortic diameter at the proximal seal zone (11%), left subclavian diameter (16%), left subclavian length to its first branch (14%), and access vessel diameter (40%).
Conclusions: Although the standard TSSB endograft can allow a more proximal seal zone and eliminate the need for open aortic arch debranching, only 30% of patients with type B dissection who require zone 2 TEVAR meet all the anatomic requirements for this device. The most common reason for failure of anatomic suitability is the proximity of the left carotid to the left subclavian origin. Objective: Our institution has noted a continual rise in the incidence of late graft failure by type III endoleak (T3EL) with early-generation AFX (Endologix, Irvine, Calif) endografts. We also noted repeated T3ELs in these patients treated with bridging AFX grafts. Previous authors noted a much lower incidence of T3EL (0%-5%) but high aneurysm-related mortality (18%) when repairing T3ELs with bridging grafts. Failure rates may be due to significant aortic remodeling in this population.
Methods: We sought to further characterize this population by instituting a targeted campaign to improve follow-up of 107 patients who had endovascular aneurysm repair with early-generation AFX devices. We then analyzed clinical and radiographic data including index procedures, anatomic data, and clinical follow-up between 2009 and 2018.
Results: Of 107 patients with early-generation AFX grafts, 26 developed T3EL (24.3%). Computed tomography scan follow-up was obtained in 63.1%. Complete endograft relining occurred in 22 patients; indications were type IIIA (4) and type IIIB (18) endoleaks. Concomitant leaks included type IA endoleak (one), type IB endoleak (two), and migration (one). Complete endograft relining was performed with 100% technical success. After relining, all patients had resolution of T3EL and all associated endoleaks, on both angiography and follow-up computed tomography scan to date. Endografts used include Excluder (two; W. L. Gore & Associates, Flagstaff, Ariz), Zenith (one; Cook Medical, Bloomington, Ind), and Ovation iX (TriVascular, Santa Rosa, Calif) for our most recent 19 patients (86%). Average time to reline was 45.2 months (1.6-70.4 months), and average follow-up after relining was 13 months (1.0-41.8 months). Drastic changes were noted after relining in aortic diameter (À8 mm [À1.0 mm to À38.0 mm]) and renal to aortic bifurcation lengths (À12 mm [À1.0 mm to À24.0 mm]).
Conclusions: We have shown that after initiation of a targeted followup campaign, the incidence of early Endologix AFX graft failure from T3EL is significantly higher than previously reported (24.3%). Changes to device design have improved on this issue. These patients have significant aortic remodeling potentially contributing to their failure. Adopting a complete endograft relining approach appears to take advantage of alternative locations of fixation and seal and completely excludes the previously placed endograft, achieving durable midterm outcomes while maintaining a minimally invasive approach.
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Lower Extremity Revascularization With Transmetatarsal Amputation Improves Healing and Reduces Major Amputation
Evan C. Werlin, Melinda S. Schaller, Charles B. Parks, Brooke A. Goodman, Blake T. Wallace, Monara Dini, Michael S. Conte, Alexander M. Reyzelman, Warren J. Gasper. UCSF, San Francisco, Calif
Objective: A transmetatarsal amputation (TMA) allows patients with forefoot wounds to maintain ambulatory function and preserves a sensate heel and ankle. However, healing after TMA is often compromised in older patients by peripheral artery disease (PAD). The aim of this study was to investigate the effect of lower extremity revascularization (LER) on TMA healing and prevention of major amputation.
Methods: A retrospective review was conducted of all patients who had a TMA at three centers of a multicenter vascular practice from January 1, 2008, to December 31, 2016. In January 2012, a multidisciplinary limb salvage team consisting of vascular surgeons and podiatrists was established. Data on demographics, procedural details, and outcomes were collected.
Results: A total of 124 patients had 134 TMAs with a median follow-up of 1221 days (interquartile range [IQR] , 730-1757 days). The mean age was 60.9 6 11.5 years; 81% were men, 87% had diabetes, 56% had PAD, and 31% had coronary artery disease (CAD). Of 134 TMAs, 68% (91) healed, 10% (14) had recurrent wounds, and 22% (29) 
